Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Cash from Financing Activities (2024 - 2026)

Prelude Therapeutics' Cash from Financing Activities history spans 3 years, with the latest figure at -$314000.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 96.25% to -$314000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $24.7 million, a 9371.43% increase, with the full-year FY2025 number at $24.8 million, up 20780.0% from a year prior.
  • Cash from Financing Activities hit -$314000.0 in Q1 2026 for Prelude Therapeutics, down from $24.9 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for PRLD hit a ceiling of $24.9 million in Q4 2025 and a floor of -$314000.0 in Q1 2026.
  • Historically, Cash from Financing Activities has averaged $2.7 million across 3 years, with a median of -$14000.0 in 2024.
  • The widest YoY moves for Cash from Financing Activities: up 73464.71% in 2025, down 1042.86% in 2025.
  • Tracing PRLD's Cash from Financing Activities over 3 years: stood at -$34000.0 in 2024, then skyrocketed by 73464.71% to $24.9 million in 2025, then tumbled by 101.26% to -$314000.0 in 2026.
  • Business Quant data shows Cash from Financing Activities for PRLD at -$314000.0 in Q1 2026, $24.9 million in Q4 2025, and -$5000.0 in Q3 2025.